We recently made a list of Goldman Sachs’ Top Growth Investors: 34 Stocks With The Highest Investment For Growth. In this ...

Mizuho lowered the firm’s price target on Biogen (BIIB) to $207 from $251 and keeps an Outperform rating on the shares. The analyst updated ...

Happenings in Boston’s life sciences ecosystem this past week include the departure of a general partner from Apple Tree Partners for another firm, Kronos Bio seeks "strategic alternatives" and new ...

We recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we are going to take a look at ...

Tola Showunmi’s first Crawley goal saw the League One side avoid an FA Cup upset at National League Maidenhead. The Magpies were on course to reach the second round for the first time since 1886 ...

Fintel reports that on October 31, 2024, Morgan Stanley downgraded their outlook for Biogen (SNSE:BIIBCL) from Overweight to Equal-Weight. There are 1,775 funds or institutions reporting positions ...

Healthcare analytics company PurpleLab joined the Network Advertising Initiative. Biogen and Neomorph announced a multi-target research collaboration to discover and develop molecular glue degraders ...

Maidenhead United striker Tobi Sho-Silva is looking forward to "testing his wits" against "better opposition" when his side take on Crawley Town in the FA Cup first round on Saturday. League One ...

Biogen Inc. (NASDAQ:BIIB) the central nervous system disease drug developer based in Cambridge Massachusetts, reported its Q3 earnings yesterday, Wednesday, October 30. First, let's look at some ...